NASDAQ, AKRX - Akorn Inc
We manufacture and market diagnostic and therapeutic pharmaceuticals in
specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes,
among others. Our customers include physicians, optometrists, hospitals,
wholesalers, group purchasing organizations and other pharmaceutical companies.
We are a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In
1997, we relocated our headquarters and certain operations to Illinois. We have
a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in
Somerset, New Jersey and is involved in manufacturing, product development, and
administrative activities related to our ophthalmic and hospital drugs &
injectables segments.
During the fiscal years ended December 31, 2005 and 2006 and for the nine
months ended September 30, 2007, we had three reporting segments. Our reportable
segments are based upon internal financial reports that disaggregate certain
operating information. ...
Read SEC Filing on NASDAQ.com »